コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 EPD at 0.4 V in a solution of Au NPs prepared with a sho
2 EPD is based on ablative fractional laser or microneedle
3 EPD of OVA induced anti-OVA antibody titer at a level co
4 EPD of three modified oligodeoxynucleotides, a methylate
5 EPD of vaccinia virus encoding OVA induced significantly
6 EPD significantly improves the quality of spatial segmen
7 EPD use was associated with a similar adjusted risk of d
8 EPDs were associated with a slightly higher incidence of
9 EPDs were used in 21.2% of saphenous vein grafts (median
11 ted by activated-electron photodetachment (a-EPD), which uses 193-nm photons to create charge reduced
12 enzymes laccase and catalase by means of AC-EPD did not inhibit each other and carry out approximate
14 ling with deposition of enzyme under ECD and EPD are considered including surface charge of enzyme, i
17 including the mannose-binding motifs EPN and EPD and the conserved WND motif that is required for bin
18 re claims to examine the association between EPD use and both procedural and long-term outcomes among
19 isease, the progression date was predated by EPD by <or= 60 days in 31%, 61 to 180 days in 15%, and m
26 pe, taken from the European Pollen Database (EPD) to produce a first synthesis of pan-European land c
28 micro-fractional epidermal powder delivery (EPD) is developed to facilitate skin vaccination and min
29 e spatial domain, edge-preserving denoising (EPD), which exploits the spatial relationships between R
31 e size-dependent electrophoretic deposition (EPD) of citrate-stabilized Au nanoparticles (NPs) onto i
33 of nHfO2@RGO and electrophoretic deposition (EPD) technique was used for its deposition onto ITO coat
34 sition (ECD) and electrophoretic deposition (EPD), in enzyme immobilization onto miniaturized electro
37 dation to use of embolic protection devices (EPD) for saphenous vein graft (SVG) intervention; howeve
40 ly by the use of embolic protection devices (EPDs), neither the level of baseline risk nor the benefi
42 llowing early signal of progressive disease (EPD) criterion based on serum CA-125: for patients with
43 alled electron photodetachment dissociation (EPD), results in abundant sequence ions in terms of w, z
47 controlled trials and 1 registry evaluating EPDs in SVG percutaneous coronary intervention (n=3958 p
49 essel revascularization; however, it favored EPD use in all-cause mortality and major adverse cardiov
54 ggests no apparent benefit in routine use of EPD during SVG intervention in the contemporary real-wor
55 valuate long-term outcomes in routine use of EPD, and meanwhile, current guideline recommendations on
57 consistent treatment benefit with the use of EPDs across the range of patients tested in randomized t
59 ealing wounds following ablative procedures, EPD is challenging to treat and may require the use of a
67 arotid artery intervention using filter-type EPDs, we have observed cases in which there is angiograp
71 ents were women in their 50s or 60s for whom EPD was deemed to be the best diagnosis, after infection
72 3) comparing SVG intervention performed with EPD (n=11 506) and without EPD (n=41 387) were included.
73 Slow-flow during carotid intervention with EPDs is a frequent event that is associated with an exce
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。